Brain anatomy of symptom stratification in schizophrenia: a voxel-based morphometry study

References

• Mitelman SA, Brickman AM, Shihabuddin LE, Newmark A, Hazlett EA, Haznedar MM, et al. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. NeuroImage 2007;37:449–62.
   PubMed Web of Science ®Google Scholar
• Dusi N, Bellani M, Perlini C, Squarcina L, Marinelli V, Finos L, et al. Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study. Schizophr Res 2017;179:104–11.
   PubMed Web of Science ®Google Scholar
• Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry 2007;64:521–9.
   PubMed Web of Science ®Google Scholar
• Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 2009;66:811–22.
   PubMed Web of Science ®Google Scholar
• Rapaport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry 2012;17:1228–38.
   PubMed Web of Science ®Google Scholar
• Silverstein BH, Bressler SL, Diwadkar VA. Inferring the dysconnection syndrome in schizophrenia: Interpretational considerations on methods for the network analyses of fMRI data. Front Psychiatry 2016;7:132.
   PubMed Web of Science ®Google Scholar
• Smyth AM, Lawrie SM. The neuroimmunology of schizophrenia. Clin Psychopharmacol Neurosci 2013;11:107–17.
   PubMed Web of Science ®Google Scholar
• Fullard JF, Halene TB, Giambartolomei C, Haroutunian V, Akbarian S, Roussos P. Understanding the genetic liability to schizophrenia through the neuroepigenome. Schizophr Res 2016;177:115–24.
   PubMed Web of Science ®Google Scholar
• Dempster E, Viana J, Mill J. Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future. Schizophr Bull 2013;39:11–16.
   PubMed Web of Science ®Google Scholar
• Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016;388:86–97.
   PubMed Web of Science ®Google Scholar
• Hong H, Kim BS, Im H. Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders. Int Neurourol J 2016;20:S2–7.
   PubMed Web of Science ®Google Scholar
• Michel TM, Sheldrick AJ, Camara S, Grunblatt E, Schneider F, Riederer P. Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia. World J Biol Psych 2011;12:588–97.
   PubMed Web of Science ®Google Scholar
• Michel TM, Thome J, Martin D, Nara K, Zwerina S, Tatschner T, et al. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. J Neural Transm 2004;111:1191–201.
   PubMed Web of Science ®Google Scholar
• Durany N, Michel T, Zochling R, Boissi KW, Cruz-Sànchez FF, Rienderer P, et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 2001;52:79–86.
   PubMed Web of Science ®Google Scholar
• Pandya CD, Kutiyanawalla A, Pillai A. BDNF-TrkB signaling and neuroprotection in schizophrenia. Asian J Psychiatr 2013;6:22–8.
   PubMedGoogle Scholar
• Premkumar P, Cooke MA, Fannon D, Peters E, Michel TM, Aasen I, et al. Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. Eur Psychiatry 2008;23:14–19.
   PubMed Web of Science ®Google Scholar
• Kim HS, Shin NY, Jang JH, Kim E, Shim G, Park HY, et al. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk. Schizophr Res 2011;130:170–5.
   PubMed Web of Science ®Google Scholar
• Krukow P, Karakuła-Juchnowicz H, Juchnowicz D, Morylowska-Topolska J, Flis M, Jonak K. Processing speed is associated with differences in IQ and cognitive profiles between patients with schizophrenia and their healthy siblings. Nord J Psychiatry 2017;71:33--41.
   PubMed Web of Science ®Google Scholar
• Penadés R, Catalán R, Puig O, Masana G, Pujol N, Navarro V, et al. Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia. Psychiatry Res 2010;177:41–5.
   PubMed Web of Science ®Google Scholar
• Andreone N, Tansella M, Cerini R, Rambaldelli G, Versace A, Marrella G, et al. Cerebral atrophy and white matter disruption in chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci 2007;257:3–11.
   PubMed Web of Science ®Google Scholar
• Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ. Systematic meta-review and quality assessment of structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012;36:1342–56.
   PubMed Web of Science ®Google Scholar
• Glahn DC, Laird AR, Ellison-Wright I, Thelen S, Robinson JL, Lancaster JL, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008;64:774–81.
   PubMed Web of Science ®Google Scholar
• Haukvik UK, Hartberg CB, Agartz I. Schizophrenia-what does structural MRI show? Tidsskr nor Laegeforen 2013;133:850–3.
   PubMedGoogle Scholar
• Rausch F, Eisenacher S, Elkin H, Englisch S, Kayser S, Striepens N, et al. Evaluation of the 'Jumping to conclusions' bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria. Psychol Med 2016;46:2071–81.
   PubMed Web of Science ®Google Scholar
• Derntl B, Michel TM, Prempeh P, Backes V, Finkelmeyer A, Schneider F, et al. Empathy in individuals clinically at risk for psychosis: brain and behaviour. Br J Psychiatry 2015;207:407–13.
   PubMed Web of Science ®Google Scholar
• Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, et al. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatr Scand 2014;130:214–26.
   PubMed Web of Science ®Google Scholar
• Koutsouleris N, Gaser C, Jäger M, Bottlender R, Frodl T, Holzinger S, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage 2008;39:1600–12.
   PubMed Web of Science ®Google Scholar
• Nenadic I, Sauer H, Gaser C. Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology. Neuroimage 2010;49:1153–60.
   PubMed Web of Science ®Google Scholar
• Zhang T, Koutsouleris N, Meisenzahl E, Davatzikos C. Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis. Schizophr Bull 2015;41:74–84.
   PubMed Web of Science ®Google Scholar
• Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001;58:148–57.
   PubMed Web of Science ®Google Scholar
• Kerns JG, Lauriello J. Can structural neuroimaging be used to define phenotypes and course of schizophrenia? Psychiatr Clin North Am 2012;35:633–44.
   PubMed Web of Science ®Google Scholar
• Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, et al. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry 1998;43:783–93.
   PubMed Web of Science ®Google Scholar
• Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, et al. Progressive cortical change during adolescence in childhood-onset schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 1999;56:649–54.
   PubMed Web of Science ®Google Scholar
• Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998;55:145–52.
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Mukra S, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998;155:678–85.
   PubMed Web of Science ®Google Scholar
• Nenadic I, Smesny S, Schlösser RG, Sauer H, Gaser C. Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study. Br J Psychiatry 2010;196:412–13.
   PubMed Web of Science ®Google Scholar
• Neckelmann G, Specht K, Lund A, Ersland L, Smievoll AI, Neckelmann D, et al. Mr morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations. Int J Neurosci 2006;116:9–23.
   PubMed Web of Science ®Google Scholar
• Picard H, Amado I, Mouchet-Mages S, Olié JP, Krebs MO. The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull 2008;34:155–72.
   PubMed Web of Science ®Google Scholar
• Levitt JJ, McCarley RW, Nestor PG, Petrescu C, Donnino R, Hirayasu Y, et al. Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: clinical and cognitive correlates. Am J Psychiatry 1999;156:1105–7.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Quarantelli M, Volpe U, Mucci A, Cassano GB, Invernizzi G, et al. Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull 2008;34:393–401.
   PubMed Web of Science ®Google Scholar
• Gupta CN, Calhoun VD, Rachakonda S, Chen J, Patel V, Liu J, et al. Patterns of Gray matter abnormalities in schizophrenia based on an international mega-analysis. Schizophr Bull 2015;41:1133–42.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Lui S, Deng W, Yao L, Zhang W, Li S, et al. Altered cortical thickness related to clinical severity but not the untreated disease duration in schizophrenia. Schizophr Bull 2015;41:201–10.
   PubMed Web of Science ®Google Scholar
• Özdemir HI, Eker MÇ, Zengin B, Yılmaz DA, İşman Haznedaroğlu D, Çınar C, et al. Gray matter changes in patients with deficit schizophrenia and non-deficit schizophrenia. Turk Psikiyatri Derg 2012;23:237–46.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Publishing; 2013.
   Google Scholar
• Tansella M, Burti L. Integrating evaluative research and community-based mental health care in Verona, Italy. Br J Psychiatry 2003;183:167–9.
   PubMed Web of Science ®Google Scholar
• Wing, 1992. WHO schedules for clinical assessment in neuropsychiatry. Geneva: World Health Organization.
   Google Scholar
• Ventura J, Green MF, Shaner A, Liberman RP. Training and quality assurance with the Brief Psychiatric Rating Scale: “The drift busters”. Int J Methods Psychiatric Res 1993;3:221–44.
   Web of Science ®Google Scholar
• Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry 2005;187:366.
   PubMed Web of Science ®Google Scholar
• Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York (NY): Thieme; 1988.
   Google Scholar
• Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: A meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005;162:2233–45.
   PubMed Web of Science ®Google Scholar
• Guo W, Hu M, Fan X, Liu F, Wu R, Chen J, et al. Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: A study of drug naive, first-episode schizophrenia patients and unaffected siblings. Schizophr Res 2014;159:43–50.
   PubMed Web of Science ®Google Scholar
• Hu M, Li J, Eyler L, Guo X, Wei Q, Tang J, et al. Decreased left middle temporal gyrus volume in antipsychotic drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings. Schizophr Res 2013;144:37–42.
   PubMed Web of Science ®Google Scholar
• Brent BK, Thermenos HW, Keshavan MS, Seidman LJ. Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: A review of structural MRI findings. Child Adolesc Psychiatr Clin N Am 2013;22:689–714.
   PubMed Web of Science ®Google Scholar
• Nestor PG, Onitsuka T, Gurrera RJ, Niznikiewicz M, Frumin M, Shenton ME, et al. Dissociable contributions of MRI volume reductions of superior temporal and fusiform gyri to symptoms and neuropsychology in schizophrenia. Schizophr Res 2007;91:103–6.
   PubMed Web of Science ®Google Scholar
• Antonova E, Sharma T, Morris R, Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 2004;70:117–45.
   PubMed Web of Science ®Google Scholar
• Premkumar P, Kumari V, Corr PJJ, Fannon D, Sharma T. Neuropsychological function–brain structure relationships and stage of illness: An investigation into chronic and first-episode schizophrenia. Psychiatr Res Neuroimag 2008;162:195–204.
   PubMed Web of Science ®Google Scholar
• Onitsuka T, Shenton ME, Kasai K, Nestor PG, Toner SK, Kikinis R, et al. Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia. Arch Gen Psychiatry 2003;60:349–55.
   PubMed Web of Science ®Google Scholar
• Kasai K, Iwanami A, Yamasue H, Kuroki N, Nagakome K, Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 2002;43:93–110.
   PubMed Web of Science ®Google Scholar
• Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H. Neuroanatomy of “hearing voices”: a frontotemporal brain structure abnormality associated with auditory hallucinations in schizophrenia. Cereb Cortex 2004;14:91–6.
   PubMed Web of Science ®Google Scholar
• Strik W, Dierks T, Hubl D, Horn H. Hallucinations, thought disorders, and the language domain in schizophrenia. Clin EEG Neurosci 2008;39:91–4.
   PubMed Web of Science ®Google Scholar
• Li X, Branch CA, DeLisi LE. Language pathway abnormalities in schizophrenia: a review of fMRI and other imaging studies. Curr Opin Psychiatry 2009;22:131–9.
   PubMed Web of Science ®Google Scholar
• Durany N, Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry 2004;19:326–37.
   PubMed Web of Science ®Google Scholar
• Hunsberger J, Austin DR, Henter ID, Chen G. The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues Clin Neurosci 2009;11:333–48.
   PubMedGoogle Scholar
• Scherk H, Falkai P. Effects of antipsychotics on brain structure. Curr Opin Psychiatry 2006;19:145–50.
   PubMed Web of Science ®Google Scholar
• Bottmer C, Bachmann S, Pantel J, Essig M, Amann M, Schad LR, et al. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 2005;140:239–50.
   PubMed Web of Science ®Google Scholar
• Ho BC, Mola C, Andreasen NC. Cerebellar dysfunction in neuroleptic naïve schizophrenia patients: clinical, cognitive and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry 2004;55:1146–53.
   PubMed Web of Science ®Google Scholar
• Bernard JA, Mittal VA. Cerebellar-motor dysfunction in schizophrenia and psychosis-risk: the importance of regional cerebellar analysis approaches. Front Psychiatry 2014;5:160.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Pearson R. The role of the cerebellum in schizophrenia. Biol Psychiatry 2008;64:81–8.
   PubMed Web of Science ®Google Scholar
• Lungu O, Barakat M, Laventure S, Debas K, Proulx S, Luck D, Stip E. The incidence and nature of cerebellar findings in schizophrenia: A quantitative review of fMRI literature. Schizophr Bull 2012;39:797–806.
   PubMed Web of Science ®Google Scholar
• Picard H, Amado I, Mouchet-Mages S, Olié JP, Krebs MO. The role of cerebellum in schizophrenia: An update of clinical, cognitive and functional evidences. Schizophr Bull 2007;34:155–72.
   PubMed Web of Science ®Google Scholar
• Ackermann H, Mathiak K, Riecker A. The contribution of the cerebellum to speech production and speech perception: Clinical and functional imaging data. Cerebellum 2007;6:202–13.
   PubMed Web of Science ®Google Scholar
• Ben-Yehudah G, Guediche S, Fiez JA. Cerebellar contributions to verbal working memory: Beyond cognitive theory. Cerebellum 2007;6:193–201.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, Paradiso S, O'Leary DS. “Cognitive dysmetria” as an integrative theory of schizophrenia: A dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 1998;24:203–18.
   PubMed Web of Science ®Google Scholar
• Hirjak D, Wolf RC, Wilder-Smith EP, Kubera KM, Thomann PA. Motor abnormalities and basal ganglia in schizophrenia: evidence from structural magnetic resonance imaging. Brain Topogr 2015;28:135–52.
   PubMed Web of Science ®Google Scholar
• Levitt JJ, Bobrow L, Lucia D, Srinivasan P. A selective review of volumetric and morphometric imaging in schizophrenia. Curr Top Behav Neurosci 2010;4:243–81.
   PubMedGoogle Scholar
• Vita A, De Peri L, Deste G, Barlati S, Sacchetti E. The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging. Biol Psychiatry 2015;78:403–12.
   PubMed Web of Science ®Google Scholar